NCAA ex-athlete backs unpaid Little Leaguers in TV money trial
The outcome will determine whether the NCAA, which treats student-athletes as amateurs, has to stop barring them from negotiating their own deals in games that are broadcast.
The outcome will determine whether the NCAA, which treats student-athletes as amateurs, has to stop barring them from negotiating their own deals in games that are broadcast.
The agreement was announced hours before the NCAA went to federal court in California to defend itself against a class-action lawsuit from former players over use of their images in broadcasts and video games.
BMV Commissioner Don Snemis said the judge's order would force the agency to issue personalized plates with offensive references to race, religion or sexual orientation.
The case, brought by former UCLA basketball star Ed O'Bannon, could determine whether the NCAA has to negotiate with players seeking to be paid for appearing in televised games without forfeiting scholarships.
Agents collected documents from the Indiana Math and Science Academy this week as part of court-ordered search warrant. The school at 7435 N. Keystone Ave. said it provided information related to a federal grant program.
Seth Beoku Betts persuaded the university to give him money to invest in collateralized mortgage obligations. His attorney say he lost the money through bad investments, but prosecutors say he spent much of it on himself, including buying a $1.5 million home in Florida.
The lender for the Hawthorns Golf & Country Club is an affiliate of California-based Concert Golf Partners, which hopes to convert its debt into ownership of the Fishers club.
Hrond Arman Gasparian, 67, was involved in two separate but related schemes, according to prosecutors. One involved stealing $400,000 from an Indianapolis church.
Quarles & Brady is the latest large law firm to expand to Indianapolis, and it plans to make a splash with a platoon of attorneys in high-profile office space.
Indianapolis law firm Cohen & Malad LLP filed suit Monday against the Indiana Department of Child Services that claims the state failed to pay millions of dollars in promised subsidies to families who adopted children from the state foster-care system.
The U.S. Supreme Court ruled against patent holders in two cases Monday, rejecting a legal theory used to sue technology companies and requiring patents to be written with more specific language.
The settlement is with Electronic Arts and Collegiate Licensing Co., which licenses and markets college sports, and does not include the NCAA. A separate case against the Indianapolis-based NCAA is scheduled for trial early next year.
The number of homicides in Indianapolis is increasing at an alarming rate, putting the city on pace to have its deadliest year in at least eight years.
Former Indianapolis Colts center Jeff Saturday and ex-Chicago Bear linebacker Hunter Hillenmeyer are suing Cleveland over what they consider an “egregious and shameless money grab.”
A judge has sentenced an Indianapolis doctor to 10 years in prison for writing illicit prescriptions for powerful painkillers after the Drug Enforcement Administration had suspended his authority to dispense controlled substances.
Alan Levin will relinquish his role as Barnes & Thornburg’s managing partner in November to Robert Grand, who leads the firm’s Indianapolis office. Levin has led the firm for 17 years.
An Indianapolis woman embezzled more than $400,000 from JP Morgan Chase in an electronic-transfer scheme that lasted eight years.
Police had filed four preliminary felony counts of possession of a controlled substance, stemming from his intoxicated driving arrest near his home in March. Prosecutors took weeks before deciding to file the misdemeanor charges instead.
The judgment in a New York court stems from allegations by a Sharia fund that the affiliates stole funds. HDG argued that it charged the additional fees to rectify a billing error.
Takeda Pharmaceutical was found not liable for the bladder cancer of two women who used its Actos diabetes medication in the company’s latest trial over the drug. Actos was marketed for Takeda in the United States by Eli Lilly and Co. from July 1999 to March 2006.